Facebook

Login

Support Sailonline

If you haven't already - join the SAILONLINE YACHT CLUB!

Please also consider making a donation - all amounts are greatly appreciated!

Profile for reenak



Name reenak
Email Address
Posts5
  • 2026-10-27 08:16:30
    Biologics Market Estimated to Experience a Hike in Growth by 2035
    Board » General Discussion
    The report titled ‘Biologics Market’ delivers a structured overview of how the industry has progressed over the years, along with expectations for future movement till 2035. This report evaluates changes in the market size and highlights important developments within the industry. It offers clarity on regional patterns, key segments, and broader structural shifts without relying on speculative forecasting.

    The global biologics market size is worth around $411 billion in 2024 and is expected to reach $962 billion by 2035, representing a higher compounded annual growth rate (CAGR) of 8.04% during the forecast period. These projections are supported by current and historical performance metrics, highlighting regional and segment-level shifts across the global landscape. The study also outlines some of the major challenges and approaches being used across industry to adapt to evolving market conditions. The market forecast section provides a grounded view of potential movements over time, based on verified data and observed patterns.

    This report includes a complete segmentation of the Biologics Market. The segmentation is based on Distribution by Historical Trend: Since 2019, Base Year: 2025, Forecast Period: Till 2035, Market Size 2035: $962 billion, Market CAGR: 8.04%, Distribution by Source, Microbial, Mammalian, Others, Distribution by Products, Monoclonal Antibodies, Vaccines, Recombinant Hormones/Proteins, Cellular-Based Therapies, Antisense and, Other Products, Application Area, Cancer Research, Infectious Diseases, Autoimmune Diseases, Rare Diseases, Cardiovascular Disorders, Hematological Disorder, Other Applications, By Drug Classification, Biosimilars, Originator Drugs, By Distribution Channel, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Key Geographical Region, North America, Europe, Asia-Pacific, Middle East and South Africa, Latin America, Key Companies Profiled, Amgen, AbbVie, Bristol-Myers Squibb Company, Celltrion Healthcare, Eli Lilly, F.Hoffmann La-Roche, GlaxoSmithKline, Johnson & Johnson, Novo Nordisk, Sanofi, Samsung BioLogics, PowerPoint Presentation(Complimentary): Available, Customization Scope: 15% Free Customization, Excel Data Packs(Complimentary), Market Landscape Analysis, Partnerships and Collaborations, Clinical Trial Analysis, Market Forecast and Future Opportunity Analysis.

    Key Geographies
    North America, Europe, Asia-Pacific, Middle East and South Africa, Latin America

    In addition to a high-level overview, the report also discusses market share shifts across these regions and the economic performance within each geography. It presents reliable estimates of projected revenue and market contribution, maintaining a neutral stance on causal relationships or future assumptions. Emphasis is placed on identifying key structural elements influencing Biologics Market growth across different regional and application-based divisions. [Origin of Information: https://www.rootsanalysis.com/reports/biologics-market.html]

    The report features a detailed assessment of leading market participants, highlighting companies such as Amgen, AbbVie, Bristol-Myers Squibb Company, Celltrion Healthcare, Eli Lilly, F.Hoffmann La-Roche, GlaxoSmithKline, Johnson & Johnson, Novo Nordisk, Sanofi, Samsung BioLogics. These companies have been profiled based on product focus, regional activity, and general business operations. The section on top companies in Biologics Market also evaluates how these firms have positioned themselves in response to market shifts, and how their current portfolios align with observed demand.

    Additional insights include the review of pricing models, cost structures, and supply chain operations relevant to the Biologics Market. The report includes discussion on raw material access, cost flow, distribution patterns, and processing rates, offering a deeper look at how value is created and maintained across different stages of production and delivery.

    The study also references recent strategic activities such as acquisitions, product launches, and geographic expansions. These developments are discussed in the context of how they impact competitive intensity and operational shifts within the Biologics Market. The analysis remains factual, highlighting observed actions without assigning subjective or future-looking projections.

    Research Methodology
    The methodology for this report includes both primary and secondary data collection from credible industry sources. Analysts have compiled information from public filings, interviews, industry portals, and market databases to ensure a high standard of accuracy. This approach ensures that the data used in the Biologics Market analysis is robust and suitable for industry decision-making.

    For any questions or to request a customized version of this report, please contact our team. We’re available to help tailor the study to your specific needs and areas of interest.

    --- Last Edited by reenak at 2026-10-27 08:16:42 ---
  • 2026-10-19 05:32:17
    Single Use Downstream Bioprocessing Market Research Accure Strong Growth in Forecast to 2035
    Board » General Discussion
    A recently published research report on the Single Use Downstream Bioprocessing Market delivers a thorough analysis of historical trends and future projections till 2035. The article offers an overview of how the market has evolved in terms of size, structure, and geographic performance. It presents factual insights into how various regions and application areas have contributed to the overall expansion of this market in recent years.

    The global single use downstream bioprocessing market, valued at USD 3.78 billion in 2025 , is projected to reach USD 4.21 billion in 2026 and USD 12.15 billion by 2035 , with a 12.5% CAGR during the forecast period 2026 to 2035. The research takes a grounded approach in presenting its findings, focusing on performance indicators across segments and territories without making speculative claims. Key developments, general industry behavior, and practical observations form the basis of the market forecast provided within this article.

    The article segments the market by Distribution by Historical Trend: Since 2022, Forecast Period: Till 2035, Market Size 2026: USD 4.21 Billion, Market Size 2035: USD 12.15 Billion, CAGR (Till 2035): 12.5%, Key Players Profiled, 3M, CPC (Colder Products Company), Cytiva Lifesciences, Merck KGaA, Repligen, Sartorius, Tezalon Biotech, Thermo Fisher Scientific, Segments Covered, Type of Product, Scale of Operation, End User, Geographical Regions.

    Key Geographies

    North America, Europe, Asia-Pacific, Rest of the World

    Geographic segmentation includes revenue performance and estimated demand across each of these key regions. The analysis reviews how various territories contribute to the Single Use Downstream Bioprocessing Market share and what role regional market conditions may play in shaping future growth. Without introducing speculative drivers, the research presents regional estimates based on verified indicators and current availability of products and infrastructure.

    Origin of Information: https://www.rootsanalysis.com/reports/single-use-downstream-bioprocessing-market.html

    A core section of the report profiles some of the top companies in Single Use Downstream Bioprocessing. These include 3M, CPC (Colder Products Company), Cytiva Lifesciences, Merck KGaA, Repligen, Sartorius, Tezalon Biotech, Thermo Fisher Scientific. The article reviews their regional presence, product strategy, and manufacturing or distribution strengths. The focus remains on factual descriptions of business operations and their contributions to the broader Single Use Downstream Bioprocessing Market growth. While market positions may differ, each company’s strategic alignment, sales footprint, and application coverage are considered as part of the competitive assessment.

    Additional insights include a review of pricing trends, supplier relationships, cost structures, and how materials flow across production stages. The research highlights interactions between upstream and downstream segments, giving readers a view into the broader functioning of the Single Use Downstream Bioprocessing industry. These insights are grounded in observed practices and data rather than hypothetical or promotional interpretations.

    Strategic developments such as acquisitions, expansions, and regional market entries are also included in the analysis. The article outlines these shifts in the context of their immediate impact, without speculating on long-term consequences or performance outcomes. Information is included to help readers understand where the industry is today and how recent activity reflects changing market priorities.

    Research Methodology
    The research team employed a combination of primary and secondary data sources to compile this report. Sources include public filings, interviews, industry databases, and internal assessments. All information presented has been reviewed for accuracy and consistency. This approach ensures a balanced understanding of the biopesticides industry for readers seeking reliable and actionable insights.

    For further clarification or to request a customized version of this report, feel free to reach out. Our team is ready to help with any specific business needs related to the Single Use Downstream Bioprocessing Market.

    --- Last Edited by reenak at 2026-10-19 05:32:59 ---
  • 2026-10-13 08:52:59
    Defining the Modern Intelligence Firm: Who Is Roots Analysis?
    Board » General Discussion
    The intersection of highly technical healthcare industries and commercial strategy requires a specific kind of business intelligence one that goes beyond surface-level data collection to deliver genuinely actionable insights. For organizations navigating the complex and heavily regulated sectors of pharmaceuticals, biotechnology, and broader healthcare, finding reliable, niche market data is a persistent and costly challenge. This is the exact operational gap that Roots Analysis was established to fill. Operating as a specialized market research, competitive intelligence, and strategic consulting firm, Roots Analysis provides deep industry knowledge tailored specifically for the life sciences ecosystem.



    What does Roots Analysis do? The company produces research-based reports and handbooks along with customized consulting services. These are primarily for clients who include corporate strategy teams, investors, and professional services firms. The reports produced by Roots Analysis usually cover Market Scenarios that are less developed or new in the areas of Bioprocessing and certain areas of Healthcare. The firm does not produce reports that cover conventional or large market scenarios.



    For a corporate strategy director at a large biotechnology firm, this specialization might mean utilizing a Roots Analysis report to understand the commercial potential and manufacturing bottlenecks of a specific cell therapy. For a venture capital firm, it could involve commissioning custom research to map the competitive landscape of artificial intelligence agents in healthcare or to evaluate the pipeline density of antibody-drug conjugates (ADCs).



    What makes Roots Analysis unique is that it is a vertically integrated research organization, and focuses on the pharmaceutical, medical device and life science tools industries. Generalist research organizations often create confusion in their clients’ minds by dabbling in too many markets and tying to cover heavy industry and health care in the same framework. Dedicating its resources to understanding the distinct market, regulatory and competitive environment of health care and life sciences, enables Roots Analysis to analyze markets with greater clarity.

    By prioritizing rigorous methodology and structured analytical frameworks, the firm enables decision-makers to benchmark clinical and commercial trends accurately. With over a decade of proprietary research, tracking tens of thousands of companies and analyzing more than a million distinct data points, the organization has built a massive foundational intelligence layer.



    With a growing base of over 1,500 global clients, ranging from boutique advisory firms to massive multinational pharmaceutical conglomerates, the firm has proven its ability to deliver value across different organizational scales. The intelligence provided supports a variety of critical functions, including market expansion strategies, licensing deal valuations, and competitive positioning. Whether a company is looking to enter a new geographic region or assess the threat posed by a novel medical technology, Roots Analysis supplies the objective, verified data necessary to move forward with confidence.



    Ultimately, Roots Analysis functions as a strategic intelligence partner, translating dense industry developments, clinical trial results, and regulatory shifts into the actionable evidence required to drive corporate strategy, market expansion, and critical investment decisions. Businesses rely on this specialized intelligence not just to understand what is happening in the market today, but to forecast where the industry is heading tomorrow. Through this commitment to technical accuracy and commercial relevance, Roots Analysis has firmly established itself as a critical resource for healthcare and life sciences organizations worldwide.

  • 2026-10-08 06:55:30
    Manufacturing Execution System Market, Forecast and Trends Till 2035
    Board » General Discussion
    Release Date: 2026-Oct-08
    The report titled ‘Manufacturing Execution System Market’ delivers a structured overview of how the industry has progressed over the years, along with expectations for future movement till 2035. This report evaluates changes in the market size and highlights important developments within the industry. It offers clarity on regional patterns, key segments, and broader structural shifts without relying on speculative forecasting.
    These projections are supported by current and historical performance metrics, highlighting regional and segment-level shifts across the global landscape. The study also outlines some of the major challenges and approaches being used across industry to adapt to evolving market conditions. The market forecast section provides a grounded view of potential movements over time, based on verified data and observed patterns.
    This report includes a complete segmentation of the Manufacturing Execution System Market. The segmentation is based on Distribution by Historical Trend: Since 2022, Forecast Period: Till 2035, Market Size 2026: USD 5.36 Billion, Market Size 2035: USD 20.46 Billion, CAGR (Till 2035): 16.0%, Type of Deployment, Cloud, Corporate Data Center, Hybrid, On Premise, Type of End-User, Life Science / Biotechnology Companies, Medical Device Providers, Pharmaceutical Companies and Others, Key Geographical Regions, North America, Europe, Asia Pacific, Latin America, Middle East and North Africa, Key Companies Profiled, Andea, Critical Manufacturing, Dassault Systèmes, GE Digital, Infor, Körber, Rockwell Automation, PowerPoint Presentation(Complimentary): Available, Customization Scope: 15% Free Customization, Excel Data Packs(Complimentary), Market Landscape Analysis for Manufacturing Market Landscape Analysis, Partnerships and Collaborations, Company Competitiveness Analysis, Value Creation Framework, Market Forecast and Opportunity Analysis.
    Key Geographies
    North America, Europe, Asia Pacific, Latin America, Middle East and North Africa
    In addition to a high-level overview, the report also discusses market share shifts across these regions and the economic performance within each geography. It presents reliable estimates of projected revenue and market contribution, maintaining a neutral stance on causal relationships or future assumptions. Emphasis is placed on identifying key structural elements influencing Manufacturing Execution System Market growth across different regional and application-based divisions. [Origin of Information: https://www.rootsanalysis.com/reports/manufacturing-execution-systems-market.html]
    The report features a detailed assessment of leading market participants, highlighting companies such as Andea, Critical Manufacturing, Dassault Systèmes, GE Digital, Infor, Körber, Rockwell Automation. These companies have been profiled based on product focus, regional activity, and general business operations. The section on top companies in Manufacturing Execution System Market also evaluates how these firms have positioned themselves in response to market shifts, and how their current portfolios align with observed demand.
    Additional insights include the review of pricing models, cost structures, and supply chain operations relevant to the Manufacturing Execution System Market. The report includes discussion on raw material access, cost flow, distribution patterns, and processing rates, offering a deeper look at how value is created and maintained across different stages of production and delivery.
    The study also references recent strategic activities such as acquisitions, product launches, and geographic expansions. These developments are discussed in the context of how they impact competitive intensity and operational shifts within the Manufacturing Execution System Market. The analysis remains factual, highlighting observed actions without assigning subjective or future-looking projections.
    Research Methodology
    The methodology for this report includes both primary and secondary data collection from credible industry sources. Analysts have compiled information from public filings, interviews, industry portals, and market databases to ensure a high standard of accuracy. This approach ensures that the data used in the Manufacturing Execution System Market analysis is robust and suitable for industry decision-making.
    For any questions or to request a customized version of this report, please contact our team. We’re available to help tailor the study to your specific needs and areas of interest.
  • 2026-10-06 04:03:55
    Diabetes Drug Delivery Devices Market - Current Impact to Make Big Changes by 2035
    Board » General Discussion
    Diabetes management relies heavily on reliable drug-delivery devices, including pen injectors, insulin pumps, and related systems. Rising global prevalence of diabetes continues to drive demand for more convenient, accurate, and connected delivery options.

    At the core of this need is the Diabetes Drug Delivery Devices Market, valued at approximately USD 17–18 billion in 2025–2026 and projected to reach around USD 31 billion by 2030 at a CAGR of roughly 14%. Pen injectors and pumps remain major segments, with ongoing innovation in connected and automated systems.

    Key players include Medtronic, Novo Nordisk, Roche, Ypsomed, and others. Continued growth in the diabetes population and preference for user-friendly devices will support expansion through the end of the decade.
    Read More: https://www.rootsanalysis.com/reports/diabetes-drug-delivery-devices-market.html

Races

Next Race: 00d 00h 00m

Current Races:

ORCV Melbourne to Devonport Race 2026

Welcome to the prestigious Rudder Cup, Australia’s oldest and most iconic yacht race! For over 110 years, this legendary 196nm classic has tested sailors' strategy and endurance across the notorious Bass Strait from Melbourne to Tasmania.

Organized by the Ocean Racing Club of Victoria, this year’s battle against the unpredictable Southern Ocean features the stylish Dehler 46. Designed by Judel/Vrolijk as a proper looker and built to race, this regatta cruiser is a virtual flyer packed with modular racing upgrades. Can you master her speed and conquer the shifting elements?

Chart your course and race for glory in this historic adventure!
Race #2068
INFO by brainaid.de
Dehler 46 PARTICULARS
WX Updates:
0430 / 1030 / 1630 / 2230
Ranking: TQD - SUPBUD - SYC
Race starts: Oct 30th 03:30 Registration Open!
▶ Flash
GO TO RACE

PIC Coastal Classic Yacht Race 2026

Kia Ora, SOLers! Welcome back to Auckland for the 2026 PIC Coastal Classic! In partnership with the New Zealand Multihull Yacht Club, Sailonline is thrilled to bring you this iconic 118nm legendary sprint to Russell.

Expect the unexpected on this tricky course up the North Island's East Coast—from adrenaline-fueled spinnaker rides to nail-biting pre-dawn lulls. This year, we take on the elements in the highly popular Seacart 30. Designed by Marc Lombard, this nimble trimaran features a challenging polar that rewards pure tactical precision.

Chart your course, conquer the coastal currents, and race for ultimate bragging rights! Upon crossing the finish line in scenic Russell, the traditional reward of bacon butties and rum awaits!
Race #2067
INFO by brainaid.de
Seacart 30 PARTICULARS
WX Updates:
0430 / 1030 / 1630 / 2230
Ranking: SYC - SUPBUD - RED
RACE CLOSE: Wednesday,
October 28 at 2300 UTC.
Race starts: Oct 23rd 22:30 Registration Closed
▶ Flash
GO TO RACE

Mad Max by Balloon 2026 - Across the Outback


Mad Max Rockatansky doesn’t get to go in a balloon in any of the Legends of the Wasteland, and the Wasteland is not necessarily the Outback of Australia, but Mel Gibson and film director George Miller indubitably are… of Australia, and ballooning as reconnaissance is a main feature of the Mad Max spin-off video game, so here goes: 1500nm in a balloon from somewhere on the edge of the Outback, Goondiwindi, to cross a finish line at Fitzroy Crossing, somewhere on the edge of the Outback!
Race #1974
INFOby brainaid.de
SOL Balloon PARTICULARS
WX Updates:
0430 / 1030 / 1630 / 2230
Ranking: BOL - SYC
Race starts: Oct 14th 13:00 Registration Closed
▶ Flash
GO TO RACE

Arctic Tern - Greenland to Antarctica 2026

Welcome to the fifth leg of our MIG series. Now it's time to race the Arctic Terns, on their migration from Greenland to Antarctica, 8300 NM. This is also part of our monthly Ocean Championship, and as such the first race of OCQ4 2026. This race will be sailed in our Maxi Trimaran. Race #2061
INFO by brainaid.de
Maxi Trimaran PARTICULARS
WX Updates:
0430 / 1030 / 1630 / 2230 Ranking:
OCQ4 - OCCH - SYC - MIG
RACE CLOSE: Wednesday,
November 4 at 2300 UTC.
Race starts: Oct 05th 11:00 Registration Closed
▶ Flash
GO TO RACE

Go to race archive

SYC Ranking

  1. Sailonline Yacht Club Member KaSToR
  2. Sailonline Yacht Club Member CriticalHippo
  3. Sailonline Yacht Club Member rafa
  4. Sailonline Yacht Club Member rumskib
  5. Sailonline Yacht Club Member Panpyc
  6. Sailonline Yacht Club Member rthinman
  7. Sailonline Yacht Club Member cdhinman
  8. Sailonline Yacht Club Member BRENTGRAY
  9. Sailonline Yacht Club Member ms0689
  10. Sailonline Yacht Club Member brandystrega

View full list

Series

Mobile Client

SYC members have the benefit of access to our mobile/lightweight web client!

The mobile client